Flucelvax Injection, Suspension
Product Images NDC 83703-088

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flucelvax (NDC 83703-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bamboo Us Bidco Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6 (Image 1)

Label for Flucelvax influenza vaccine, 0.5 mL dose for intramuscular injection. The label states it is for use in individuals 6 months and older. Manufactured by Seqirus Inc. and includes US License No. 2049, barcode, lot, and expiration information (blacked out). The label highlights the 2026-2027 formulation.*

FDA Label Image

5 (Image 2)

Packaging label for Influenza Vaccine Fluzone 2026-2027 Formula. It states the vaccine contains no preservative, is for intramuscular use, and is supplied as a 0.5 mL single-dose injection. The manufacturer is Sanofi Vaccines US Inc. The label includes sections for NDC, lot, and expiration data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.